Evidence map›Paper›PMID 34275161›Full record

SynthesisAlimentary pharmacology & therapeutics2021

Systematic review with meta-analysis: neoplasia detection rate and post-endoscopy Barrett's neoplasia in Barrett's oesophagus.

Nour Hamade, Amrit K Kamboj, Rajesh Krishnamoorthi, Siddharth Singh, Leslie C Hassett, David A Katzka, Charles J Kahi, Hala Fatima, Prasad G Iyer

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Alimentary pharmacology & therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Artificial Intelligence for Esophageal Precancerous Lesions and Esophageal Cancer.The Korean journal of helicobacter and upper gastrointestinal research · 2026
    Review
  2. Review
  3. Review
  4. Quality indicators in Barrett's endoscopy: Best is yet to come.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2024
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Nour HamadeDivision of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN, USA.
Amrit K KambojDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Rajesh KrishnamoorthiDivision of Gastroenterology and Hepatology, Virginia Mason Medical Centre, Seattle, WA, USA.
Siddharth SinghDivision of Gastroenterology and Hepatology, University of California San Diego, San Diego, CA, USA.ORCID 0000-0002-2640-7269
Leslie C HassettMayo Clinic, Rochester, MN, USA.
David A KatzkaDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-2307-2317
Charles J KahiDivision of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN, USA.
Hala FatimaDivision of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN, USA.ORCID 0000-0002-9290-1441
Prasad G IyerDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-9822-1420
Mayo Clinic in Arizona · USIndiana University Indianapolis · USUniversity of California San Diego · USVirginia Mason Medical Center · US

Funding

Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal AdenocarcinomaR01CA241164 · NCI · MAYO CLINIC ROCHESTER · PI Jagpreet Chhatwal, Prasad G. Iyer · 2019 to 2026
$3.9M
Comparative Risks and Benefits of Pharmacological Therapies for Older Patients with Inflammatory Bowel DiseasesK23DK117058 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SINGH, SIDDHARTH · 2018 to 2022
$971k
Foundation for the National Institutes of Health DK117058NCI NIH HHS R01 CA241164NIDDK NIH HHS K23 DK117058
6 · The paper itself

Abstract

backgroundNeoplasia detection rate, the proportion of Barrett's oesophagus patients with high-grade dysplasia or oesophageal adenocarcinoma detected at index surveillance endoscopy has been proposed as a quality metric. However, the correlation between neoplasia detection rate and a clinically relevant outcome like post-endoscopy Barrett's neoplasia remains unknown. Post-endoscopy Barrett's neoplasia refers to the rate of high-grade dysplasia or oesophageal adenocarcinoma on repeat endoscopy within one year of an index screening examination revealing non-dysplastic Barrett's oesophagus or low-grade dysplasia.

aimTo assess correlation between neoplasia detection rate and post-endoscopy Barrett's neoplasia.

methodsWe performed a systematic search of multiple databases from date of inception to June 2021 to identify cohort studies reporting both neoplasia detection rate and post-endoscopy Barrett's neoplasia. Data from each study were pooled using a random effects model, and their correlation assessed using meta-regression. Heterogeneity was assessed and a priori planned subgroup analyses were conducted.

resultsTen studies with 27 894 patients with Barrett's oesophagus were included. The pooled neoplasia detection rate and post-endoscopy Barrett's neoplasia were 5.0% (95% CI: 3.4%-7.1%, I

conclusionWe observed a statistically significant inverse correlation between neoplasia detection rate and post-endoscopy Barrett's neoplasia. Additional studies are needed to further validate this correlation.

Indexed as

AdenocarcinomaBarrett EsophagusEsophageal NeoplasmsEndoscopyHumansHyperplasia

Identifiers

PMID34275161
PMCPMC9152697
OpenAlexW3186260139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.